Iterum Therapeutics plc·4

Feb 19, 11:29 AM ET

Matthews Judith M. 4

4 · Iterum Therapeutics plc · Filed Feb 19, 2019

Insider Transaction Report

Form 4
Period: 2019-02-15
Matthews Judith M.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-02-15+30,00030,000 total
    Exercise: $5.80Exp: 2029-02-14Ordinary Shares (30,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of February 15, 2019 (the "Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION